Predictors of Three Dose On-Time Compliance with HPV4 Vaccination in a Disadvantaged, Underserved, Safety Net Population in the US Midwest

Autor: Laura K. Hempstead, Ruud L.M. Bekkers, Jeffrey Wall, R. Stephen Griffith, Inge Verdenius, George D. Harris, Gerard J. Malnar, Diane M. Harper
Rok vydání: 2013
Předmět:
Viral Diseases
Health Screening
Pediatrics
Epidemiology
Economics
Safety net
Gynecologic Infections
Aetiology
screening and detection [ONCOL 5]
Alphapapillomavirus
Social and Behavioral Sciences
Medicine
Clinical Epidemiology
Young adult
Child
education.field_of_study
Multidisciplinary
Vaccination
Obstetrics and Gynecology
Immunizations
Socioeconomic Aspects of Health
Infectious Diseases
Female
Public Health
Behavioral and Social Aspects of Health
Research Article
Adult
Human Papillomavirus Infection
medicine.medical_specialty
Adolescent
Clinical Research Design
Science
Population
Sexually Transmitted Diseases
MEDLINE
Vulnerable Populations
Infectious Disease Epidemiology
Young Adult
Health Economics
Environmental health
Humans
Papillomavirus Vaccines
education
Primary Care
Immunization Schedule
Retrospective Studies
Adult female
Immunization Programs
business.industry
Papillomavirus Infections
Immunity
Gynecologic Cancers
Retrospective cohort study
United States
Social Epidemiology
Disadvantaged
Women's Health
Patient Compliance
Clinical Immunology
Preventive Medicine
business
Zdroj: PLoS ONE
PLoS One, 8, 8
PLoS One, 8
PLoS ONE, Vol 8, Iss 8, p e71295 (2013)
ISSN: 1932-6203
DOI: 10.1371/journal.pone.0071295
Popis: Contains fulltext : 183582.PDF (Publisher’s version ) (Open Access) BACKGROUND: HPV4 is approved as a series of three timed doses expected to result in efficacy against specific HPV infections. Completion rates in the US are quite low at the same time the structure of health care delivery is changing. The aim of this study was to determine how the patient-, clinic- and systems-level characteristics facilitate or hinder the timely completion of three HPV4 doses in both adolescent and adult female populations in a high-risk safety net population. METHODS: This is a retrospective study in which patient-, clinic- and systems-level data are abstracted from the electronic medical record (EMR) for all females 10-26 years of age receiving at least one dose of HPV4 between July 1, 2006 and October 1, 2009. RESULTS: Adults were more likely to complete the three dose series if they had at least one health care visit in addition to their HPV4 visit, (aOR = 1.54 (95% CI:1.10, 2.15). Adults were less likely to complete the three dose series if they received their second HPV4 dose at an acute health care, preventive care or postpartum visits compared to an HPV4-only visit (aOR = 0.31 (95% CI: 0.13, 0.72), 0.12 (0.04, 0.35), 0.30 (0.14, 0.62), respectively). Hispanic adults were less likely than whites to complete the series (aOR = 0.24 (95% CI:0.10, 0.59). 39% of adolescents who completed two doses completed the series. CONCLUSIONS: HPV4 is more likely to be effectively administered to adults in a safety net population if multiple health care needs can be met within the health care system.
Databáze: OpenAIRE
Externí odkaz: